Source-Omega, a finished products manufacturer and educational marketing company, announced today their new peer-reviewed publication titled "A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food," written by Dr Scott D. Doughman, PhD, CEO and Chief Scientific Officer.

Chapel Hill, NC -- (SBWIRE) -- 01/13/2012 -- The Source-Omega company's invited manuscript was accepted after independent international peer review. It is published as an academic chapter in the book Environmental Pollution: Ecology and Human Health, published by Narosa (India) [http://www.narosa.com/books_display.asp?catgcode=978-81-8487-112-8].

Source-Omega maintains its R&D is always expanding and touts its public health research focus. They are seeking to identify the largest populations with the greatest omega-3 need.

Doughman's collaborations with senior medical and scientific experts in India helped define trends in onset correlated with urbanization and modern dietary changes. He pointed out the greatest incidence of type-2-diabetes occurs in India, China and the USA, respectively (1).

Their report does not discuss relative rates of onset in these countries other than the fact that world diabetes onset is doubling every 30 years, with 200 million people worldwide diagnosed to have this largely preventable disease.

Doughman commented on the quality and safety of algae oil and the global diabetes need. "Based on a full survey of the evidence-based literature, there is a tremendous opportunity for more omega-3 research from university groups. We report how algae oil significantly and safely benefits diabetics with dyslipidemias and elevated postprandial triglycerides, without introducing any known glucose control side effects or drug interactions in this population," he said.

Lead editor of the book compilation, Dr. Gottipolu R. Reddy, is Professor and Head, Division of Neuroscience, Department of Zoology, Sri Venkateswara University, Tirupati, India. Dr. Reddy is known internationally for his research in the area of developmental neurotoxicity of heavy metals. Dr. Reddy and Dr. Doughman met at a 2009 symposia at the historic Bangalore University, Department of Zoology, where each had been invited speakers.

High-DHA algae oil has no environmental pollutants, is natural cultured oil grown in enclosed controlled systems. The safety of high-DHA omega-3 algae oil intake by a type-2-diabetic was previously published on in review by Doughman et al., 2007 (2).

Other Source-Omega publications and articles in India on algae oil topics include peer reviewed manuscripts published in 2008 with the Indian Science Congress and in 2009 by the University of Madras, Department of Zoology. Recently Doughman's Visiting Faculty work has been written about by the Asian Scientist (3,4,5).

The company suggested that future studies on environmental pollution-effects will likely show significant contributions to diabetes onset worldwide, but acknowledged that algae oil DHA can only address the chronic dietary component of the disease.

Doughman commented, "Progress is being made in educating about the two sides of the type-2-diabetes coin, sugar and fat, not just sugar."

He then added, "We should not say the cause is the 'Western diet'. Diabetes is increasing with convenience diets, affluence, urbanization and possibly pollution. To say Western diet invites cultural blame and most diabetics do not eat a Western diet, rather refined sugars, starches and oils all play contributing roles as added ingredients in processed foods made all around the world."

Current science and consensus indicates eating fish is linked to lower blood glucose concentrations and the related associations to a reduced risk of developing diabetes, discovered as a result of the Prevention with a Mediterranean Diet study conducted by Mercedes Sotos Prieto in Spain through the University of Valencia. The study was conducted with the Valencia population involving 945 people (340 men and 605 women) between the ages of 55 to 80 who had high cardiovascular risk backgrounds.

Source-Omega is a member of the Global Organization for EPA and DHA Omega-3s (GOED), a trade group advocating for the ethical and sustainable use of omega-3 fatty acids in nutrition and medicine. GOED's website [http://www.goedomega3.com] suggests omega-3 prevention measures worldwide could help save $47 trillion in chronic disease costs, including the long term complications and costs associated with the diabetes epidemic.

References:
(1) Doughman. A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food. (2011), in press, reprints available upon request.
(2) Doughman et al., Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. (2007), 3:198-203
(3) http://sciencecongress.nic.in/html/pdf/Aug_Sept_2008.pdf
(4) http://www.envismadrasuniv.org/nl20094%20articles%20Medicinal%20and%20nutritional.htm
(5) http://www.asianscientist.com/topnews/sai-baba-studied-link-omega-3-fish-oils-type-2-diabetes/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Chapel Hill, NC -- (SBWIRE) -- 03/09/2011 -- Source-Omega, LLC announces increased private investment in its growing business model since the Martek Biosciences Corporation sale in December 2010. The company references "weekly" corporate international demand for its Pure One™ algae oil product formulation using life'sDHA™, which the company also co-brands with Pure One™ for international private label contracts through Source-Omega. Also, the Source-Omega company's expert pipeline in premium sourced omega-3 products gives Source-Omega solid positions in exports, contracting, branding and medical food.

"Ours is a values-based, educational marketing program with product development services. The Pure One branded innovations have truly advanced the depth of the entire omega-3 supplement trade. Our mission is to provide pure omega-3 innovations, access and solutions to all the world's people," said Scott Doughman, PhD, President and Chief Scientist at Source-Omega. Dr. Doughman added that Source-Omega had entered the algae oil supplement manufacturing market early and helped to drive collaborative product development innovations toward successful new quality standards with value added cultural significances.

Please contact Dr. Doughman for more information at info@source-omega.com. Ph: 919-360-5275; Web: http://www.source-omega.com

About Source-Omega
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs, brain health, and for pregnancy, nursing and family care.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Chapel Hill, NC -- (SBWIRE) -- 03/07/2011 -- Source-Omega, LLC announces Optimized DHA3™ ForeBRAIN(SM) as the second product in their line of Next Gen Plant Based Omega-3™ for premium optimized vegetarian lipids. The product is planned for launch on Earth Day 2011.

Optimized DHA3™ ForeBRAIN(SM) contains select algae oil that is rich in DHA n-3 (300 mg) and DPA n-6 (100 mg) plus EPA n-3 (10 mg). Pure One™ DHA plus DPA n-6 and EPA furthers the company's proprietary 300 mg DHA 10 mg EPA formulation using algae oil.

The product will be 30 capsules for a one month supply. One capsule per day of the Pure One product is suggested to support brain structure and function in children 4 and over and in adults. Greater levels of DHA plus EPA are required to lower triglycerides for heart health in adults.

"We seek to most completely educate the consumer about how the new Pure One™ omega-3 product supports brain structure and function. The ForeBRAIN product is consistent with our prior observation that Pure One™ algae oil fatty acids are balanced to match the body's needs. This means that the human brain make-up of omegas is more closely matched by the Pure One™ ForeBRAIN product ratios" said Scott Doughman, PhD, President and Chief Scientist at Source-Omega.

Since before the company was formed, Doughman started looking at how the human brain and organs are made up in terms of omega fatty acids. He said he observed parallels between ratios and levels of omega fats in eggs, breast milk and one algae oil strain in terms of the oil fat balance and the human brain fat composition.

The DPA n-6 lipid in ForeBRAIN comes from the same Non-GMO algae strain as the first Pure One product and is safe for pregnant and nursing mothers. The company stated that it has always known the DPA n-6 potential. Source-Omega is the first to distinguish their new 35 percent DHA plus about 15 percent DPA n-6 through the Pure One™ brand.

DHA AND DPA n-6
The human forebrain contains some of the highest levels of DHA in the brain. More is being discovered about the levels of DPA n-6 in the brain, yet no dietary recommendations are currently available. Many experts recommend DHA intake of at least 300 mg per day, but with little discussion of DPA n-6, a non-inflammatory structural lipid normally found in the brain, in human breast milk and in eggs.

The Pure One™ vegetarian form of the "egg lipids" DHA, DPA and EPA together may provide greater brain support than DHA alone, although literature research on the topic is very early. 100 mg DPA n-6 per serving is considered safe and beneficial as a fatty acid that is also present in the general food supply and is safe at higher dosages. The oil is GRAS and infant formula grade, kosher and pure.

"Optimized DHA3™ ForeBRAIN(SM) has emerged out of years of research. Our published review from 2007 discusses the range and ratio of DHA n-3 to DPA n-6 in human breast milk. Optimized DHA3™ ForeBRAIN features the median ratio of 3:1 DHA/DPA found in human breast milk [REF1]," said Doughman.

About Source-Omega
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs, brain health, and for pregnancy, nursing and family care.

[REF1]: Doughman SD, Krupanidhi S, Sanjeevi CB. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. 2007 3(3):198-203.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

OMEDHA, a Medical Food for Postprandial Triglyceride Testing in Diabetics. Algae oil is the purest and safest DHA+EPA bioscience resource known, one that India needs," said Filippo Porco, an International Communication Specialist with Source-Omega.

Chapel Hill, NC -- (SBWIRE) -- 01/17/2011 -- The Source-Omega company is an innovator in DHA EPA algae oil products for heart and triglyceride applications, also in NIDDM patients. The company's first offering, Pure One™, features their flagship international formula and brand, manufactured to international standards for quality, cultural and dietary inclusion. OMEDHA(TM) is planned and formulated for Indian markets.

The Source-Omega company's second branded offering, OMEDHA™, is based on 3 years of dose-response research and a recently submitted manuscript review on the Indian diabetes dilemma and uses of algae oil omega-3s as a superior postrandial triglyceride treatment over fish oils, especially in a vegetarian and a patient with fish allergy.

Also, an academic book chapter on their algae oil medical food substitute for fish oil was accepted for 2011 publication in India.

Dr Scott Doughman, the company President and Chief Scientist will be traveling to India in February this year as a 10 year Visiting Faculty in Biosciences at the internationally renowned Sai University (SSSIHL).

"OMEDHA™ is the branded form of our Omega-3 DHA Therapy™, offered in the USA for several years to vegetarian's with high triglycerides, backed by a large and growing body of literature in humans," said Doughman, who has a PhD in Lipid Biochemistry, a former NIH funded omega-3 researcher and American Heart Association fellow.

Doughman developed the product formulation 300 mg DHA 10 mg EPA, balanced to match the body's omega-3 needs, as the first disclosed algae oil DHA EPA made in the USA, launched in early 2008.

For More information please contact 919-360-5275; info@source-omega.com; http://www.source-omega.com

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An internal Source-Omega report suggests at 3 months, high triglyceride reductions with DHA are temporally correlated with omega-3 essentiality, or saturation levels of omega-3s in red blood cell (RBC) membranes, also called the omega-3 index.

Chapel Hill, NC -- (SBWIRE) -- 11/30/2010 -- An interview this week with Baldur Hjaltason, chairman of leading marine-sourced omega-3 group the Global Organization for EPA and DHA Omega-3 (GOED), and strategic business development manager at EPAX, and Adam Ismail, GOED executive director. On November 23, 2010, when asked by Nutraingredients reporter Shane Starling about the 2.0 g DHA claim for triglycerides management, Baldur Hjaltason said, "The omega-3 industry has been driven by solid science. That is the reason we are seeing so many approved claims, because we have such a great amount of scientific data to support those claims."

The long-chain omega-3 fatty acid docosahexaenoic acid (DHA; 22:6 n-3) comprises over 80 percent of the omega-3 composition in the human body. This fact has not escaped non-fish-based advocates of algae oil DHA treatments for high triglycerides. The literature shows over 16 studies of algae oil DHA supplements providing significant improvements in hypertrygliceridemia (HTG), commonly known as high triglyceride levels above 200 mg/dl triglycerides in plasma in a fasting state.

Since high triglycerides are commonly found in type 2 diabetes subjects, Source-Omega ( http://www.source-omega.com ) recently conducted a study of the mechanisms and evidence for how DHA might protect against diabetic etiologies affected by high triglycerides. "We observed that DHA-rich microalgae oil is more effective than fish oil mixtures low in DHA at lowering high postprandial triglyceride levels," said Scott Doughman, Ph.D., Chief Scientist at Source-Omega.

Source-Omega has also been looking at the need in Asian Indian urban populations particularly at risk for HTG and diabetes onset due to factors such as urbanization, dietary changes and genetic factors inherent to the traditionally non-fish-eating population.

Source-Omega's Report Findings:

1) Clinical studies in the United States and elsewhere show DHA from microalgae oil targets HTG.

2) At 3 months, the HTG reductions with DHA are temporally correlated with omega-3 essentiality, or saturation levels of omega-3s in red blood cell (RBC) membranes, also called the omega-3 index.

3) DHA reduces triglyceride levels over 25 percent when taken at levels greater than 1000 mg daily for 3 months, doubling total omega-3 levels.

4) 1200 mg DHA per day gives about 1000 mg bioavailable DHA.

5) DHA is the major omega-3 present in neuroendocrine beta-cell membranes and in immunological cells.

6) While microalgae oil DHA studies have not been performed using insulin producing cells, fish oil studies clearly show DHA is the only accretive omega-3 in pancreatic beta-cell membranes.

7) While DHA does not affect glucose homeostasis in diabetic subjects, increases in DHA levels over time correlated with improvements in insulin secretion and insulin function, suggesting beta-cell dependent and independent mechanisms.

8) The utility of 1200 mg DHA as an optimized dosage for the reduction of moderately high HTG and a low plasma omega-3 index for optimizing health status was supported by several independent studies as a near-maximal metabolic dose for greatest results per dose.

About Source-Omega, LLC
Located in Chapel Hill North Carolina, founded in 2007, Source-Omega developed the Pure One™ Formula out of the published academic work and innovations of Scott Doughman, Ph.D., Lipid Biochemist and a former National Institutes of Health funded omega-3 researcher, previously also an American Heart Association fellow with over 12 years of lipid research experience. Since 2007, the company has rapidly grown with a focus on high triglycerides and their Omega-3 DHA Therapy™ for results oriented omega-3 dosages. The product stability, ecological sustainability, vegan and Kosher registrations and research behind Pure One™, each lend qualifications that provide value added advantages. The Pure One™ Brand and Formula are available for licensing from Source-Omega.

Press & Media Contact:
Scott D. Doughman, PhD
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Source-Omega licenses Solal Technologies of Johannesburg, South Africa, to offer novel Vegetarian Omega-3 (SM) product with DHA and EPA from sustainable algae oil source.

Chapel Hill, NC -- (SBWIRE) -- 11/30/2010 -- Source-Omega, LLC ( http://www.source-omega.com ) is now offering private labeling of its vegetarian algae oil in international markets.

The company has licensed Solal Technologies of Johannesburg, South Africa, to offer Vegetarian Omega-3 (SM).

"Solal is an ideal business partner for Source-Omega," said Dr. Scott Doughman, president and founder of Source-Omega. "Both companies have the same goal, offering a product that fills an important need not met with modern diets and lifestyle."

The oil has been licensed for sale in the South African pharmaceutical market under a "medical food" label licensed to Solal under the Pure One™ brand.

"Medical food" is a relatively new category established in the 1988 amendments to the Orphan Drug Act. The U.S. Food and Drug Administration requires that "medical foods" contain only ingredients classified as Generally Regarded as Safe (GRAS). Algae oil omega-3, which is entirely plant-based, meets this standard, however the Pure One™ label in the U.S. and South Africa are designated Dietary Supplements and are not a drug.

Solal will offer Vegetarian Omega-3 in pharmacies, behind the counter, as recommended by physicians for management of a low omega-3 index and high triglyceride levels. It will also be offered as an anti-aging non-prescription supplement. Vegetarian Omega-3 will be available directly to patients, through retail pharmacies, physicians and health stores based in South Africa.

"We are pleased to have this relationship with Source-Omega to offer a product that is so important to maintaining health," said Colin Levin, a vegetarian and a director of Solal. "This will be a win-win-win, for Solal, Source-Omega, and, most importantly, for our patients and customers."

Source-Omega is also working on expanding its markets through other private labeling arrangements outside the United States.

The basis of the oil is Source-Omega's patent-pending formula of DHA and EPA for cardiovascular, metabolic and cognitive health management, offered in supplements and medical food. Pure One™ offers optimized omega-3 dosages and clinically proven triglyceride lowering benefits with documented results.

Certain omega-3 dosages have been proven effective for management of plasma lipids. As a medical food, it can fulfill the omega-3 requirements associated with DHA and EPA deficiencies in vegetarians, people who cannot eat fish, and those with special dietary needs not met by omega-3 seed sources such as flax oil. Vegetarian Omega-3(SM) is offered in a soft carrageenan capsule.

About Solal Technologies (Pty) Ltd
Located in Johannesburg, Solal Technologies works and supplies online to physicians, pharmacies and other outlets based in South Africa. Other divisions of Solal include The Compounding Pharmacy of South Africa, an Integrative Medical Center and a Health Intelligence magazine covering the science of health. For more information please visit http://www.solaltech.com

About Source-Omega, LLC
Located in Chapel Hill North Carolina, founded in 2007, Source-Omega developed the Pure One™ Formula out of the published academic work and innovations of Scott Doughman, Ph.D., Lipid Biochemist and a former National Institutes of Health funded omega-3 researcher, previously also an American Heart Association fellow with over 12 years of lipid research experience. Since 2007, the company has rapidly grown with a focus on high triglycerides and their Omega-3 DHA Therapy™ for results oriented omega-3 dosages. The product stability, ecological sustainability, vegan and Kosher registrations and research behind Pure One™, each lend qualifications that provide value added advantages. The Pure One™ Brand and Formula are available for licensing from Source-Omega, LLC under their field of use and US patent application number 12/727,006 filed with the US Trademark and Patent Office, March 18th, 2010.

For more information please visit http://www.source-omega.com.

Press & Media Contact:
Scott D. Doughman, PhD
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Chapel Hill, NC -- (SBWIRE) -- 11/15/2010 -- Return 2 Health has an on-line store for products related to health and well-being, and it also serves naturopaths.

Source-Omega offers its distributors expertise. "We provide a well-managed partnership to our distributors," said Scott Doughman, Ph.D., president of Source-Omega. "Distributors especially appreciate our product quality and supply chain security."

Vegetarian omega-3 oils with both DHA and EPA are marketed by Source-Omega ( http://www.source-omega.com ) in the United States under the Pure One™ brand. Source-Omega's oils come from sources approved by both the U.S. Food and Drug Administration and the European Commission.

Concern for quality led Return 2 Health to add Source-Omega ( http://www.source-omega.com ) products to its offerings.

"Our product lines are from brands you can trust and are of the highest pharmaceutical grade - formulated to provide safe, quality health supplements," said Martin Thompson, Managing Director.

Source-Omega ( http://www.source-omega.com ) is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name Pure One™, Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care.

Return 2 Health was founded in 2003 and is based in Aukland. It specializes in natural health remedies.

For more information about Source-Omega, call 919-360-5275, or visit http://www.source-omega.com, or http://www.pureone-dha.com

For more information about Return 2 Health, visit http://www.return2health.net.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

"What all the human omega-3 red blood cell data independently points out is that DHA is always 3 to 8 fold more abundant than EPA in human blood and tissues, even after prolonged intake of high doses of omega-3s predominantly as EPA," says company scientist.

Chapel Hill, NC -- (SBWIRE) -- 11/12/2010 -- Today, Source-Omega ( http://www.source-omega.com ) revealed knowledge gained from their review of the omega-3 literature and published research. "What all the human omega-3 Red Blood Cell data independently point out is that DHA is always 3 to 8 fold more abundant than EPA in human blood and tissues, even after prolonged intake of high doses of omega-3s predominantly as EPA," says Scott Doughman, PhD., Chief Scientist at Source-Omega.

Source-Omega revealed their discussion, forwarding that composition studies in 1978 proved DHA is naturally the most abundant omega-3 form in the human body and blood in comparison to EPA levels in untreated individuals (Sanders et al., 1978). In 1986, a review by Herold and Kinsella of human volunteers treated with fish oil omega-3s revealed higher DHA fatty acid composition in red blood cells compared to EPA, despite high EPA intake (Herold and Kinsella, 1986).

Fish oils have been an abundant source of EPA, so fewer studies may have taken into consideration that DHA is the most abundant omega-3 long chain fatty acid because EPA was the main omega-3 given as a fish oil treatment.

When Conquer and Holub published on algae oil DHA treatment of human subjects in 1996, a detailed double-blind randomized placebo controlled study, the authors found blood omega-3 parameters consistent with humans taking high dosages of fish oil (Conquer and Holub, 1996). The 1996 study showed RBC increases in both DHA and EPA through accretion of DHA and retroconversion of DHA. Other metabolism studies have shown DHA is also a template that will provide all the C22, C20, and C18 omega-3s needed in the body through retroconversion, say Source-Omega scientists.

DHA delivers saturation levels of omega-3s to RBC membranes when the DHA dosage ( http://www.source-omega.com ) for adult clinical use begins with 1.0 g to 1.2 g DHA per day, which company results, or previous published studies show can provide saturation levels of omega-3s within 90 days (Arterburn et al., 2008).

The scientific literature shows high-dose DHA derived from microalgae lowers hypertriglyceridemia after 90 days of treatment, by up to 26 percent with at least 1 g DHA daily (reviewed by Ryan et al., 2009). With a safe, effective dosage range for any adult, the GRAS safety registration of algae oil and the dosage range have been positively ruled-upon, as such, by several international regulatory bodies.

"The summary of these historical studies together suggest 'directional omega-3 metabolism', where fish oil is 'uphill' and algae oil is 'downhill'. EPA intake leads to multistep synthesis to DHA with fish oil. DHA intake leads to a single step retroconversion to EPA with algae oil. The body knows how to balance its final levels from each direction, but 'downhill' appears more efficient at high omega-3 doses," said Doughman.

Each method then flows towards a somewhat pre-defined homeostatic balance of cellular and tissue specific omega-3 compositions, the data suggest.

Since the DHA retroconvertion dosing strategy is the opposite of fish oil, Source-Omega's ( http://www.source-omega.com ) patent pending claims are on the dosage use and method of 1200 mg DHA + 40 mg EPA per day as metabolically ideal for certain health claims and postprandial triglyceride lowering benefits [References Available upon request from Source-Omega].

About Source-Omega
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Source-Omega's Pure One brand moves towards private label offering and licensing in a growing market with green economic outlook. Estimated at $400M, the total European omega-3 market is now doubling every 10 years.

Chapel Hill, NC -- (SBWIRE) -- 08/17/2010 -- Source-Omega's Pure One™ branded products ( http://www.source-omega.com ) move towards international private label deals, offering contracts, access and licensing to a growing global omega-3 market with growing global green economic outlooks.

"In Europe there is a strong compliance record for our algae oil source," said Scott Doughman, PhD, President of Source-Omega, LLC maker of the Pure One™ omega-3 algae oil brand.

Evidence-based omega-3 fatty acid benefits from eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) gives ongoing usage credibility for polyunsaturated fatty acids (PUFAs) as an adjunct to diet for condition specific uses. EPA and DHA are the "good fats" considered almost essential to combat the effects of the modern diet.

With 50% global urban populations carrying excess weight plus heightened consumer awareness regarding high dose omega-3 benefits, connections made between 'need' and 'use' is answered, yet the question remains as to what sources and dosing strategies are best for each application.

"With our standardized dosing program, our algae oil is disclosed for use in our patent pending accretion therapy to end omega-3 deficiency in a person in three months, pure and simple," said Doughman, who claims Pure One™ algae oil is balanced to match the body's omega-3 needs.

Consumers hope to find solutions to fish sustainability and seawater pollution issues. Many are putting algae oil omega-3s squarely in the scope of comparison to fish oil. While algae oil dietary supplements makers still seek greater distribution, new analysis from Frost & Sullivan ( http://www.food.frost.com ), titled Strategic Analysis of the European Marine and Algae Oil Omega-3 Ingredients Market, finds that algae oil is clearly part of the total omega-3 benefits market.

Algae oil made in the U.S. is good on the topics of shelf-placement, regulatory and compliance topics. For more information, for example, GOED and Purdue University in the U.S. established the Omega-3 Learning Consortium for Health and Medicine to provide credible information about omega-3 fatty acids.

With many algae oil omega-3 distribution challenges still to overcome, positive media coverage seems to abound around the benefits for ageing populations facing chronic illness such as diabetes, heart disease and Alzheimer's disease. With the topic of medical food emerging, how to classify omega-3s is not yet understood by doctors or consumers. Consumers are still rapidly trying to learn on their own to differentiate between what they hear and read and what the doctor recommends.

Manufacturers of algae oil supplements ( http://www.source-omega.com ) recognize the link between consumer awareness and product marketability for branding the active ingredients into functional foods, supplements, and medical foods. The European Parliament has approved nutrition claims for omega-3s to apparently encourage greater daily doses and omega-3 usage across Europe.

About Source-Omega, LLC
Source-Omega is located near the Research Triangle Park and was founded in 2007 for specializing in the manufacturing, branding, and globalization of algae oil nutritional products as an exclusive distributor of the brand name Pure One™, Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care. Dr. Scott Doughman, Ph.D. Phone: +19193605275, Web: http://www.pure-one.eu; http://www.source-omega.com; http://www.pureone-DHA.com.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Pure One™ DHA supplement manufacturer today announced a license from the Vegan Society for trademark use in the United States, Canada, the European Union, and Australia. The Vegan logo adds to Pure One’s quality offering for vegetarian consumers and vegan retailers, in addition to the benefits of being sourced and Made in the USA and recognized good for pregnant-nursing mothers and infants.

Chapel Hill, NC -- (SBWIRE) -- 05/23/2010 -- Could Pure One™ be the "4G" of omega-3s? Pure One™ Next Generation Plant Based Omega-3™ may qualify as a brilliant leap forward in omega-3s. Pure One™ is DHA-rich oil from a pure cultured algal source. The oil has significant scientific research backing, a patent pending metabolic ratio of DHA and EPA for the same omega-3s that are found in fish oils, but without the fish. Pure One™ is from one source, not a mixture, and is a pure sustainable product made in a breakthrough vegan softgel, also from natural algae sources. The product is free of animal products, GMO's, wheat & gluten, soy, hexane, fragrance, flavorings, dyes, toxins, allergens, pollutants and heavy metals. See www.PureOne-DHA.com for product information.

"Our research and development brought to market the first and only metabolic ratio of DHA and EPA omega-3s. We are educating consumers that Pure One™ is proven to replace fish oil, dose for dose, for the heart and brain, eliminating the need for the world to harvest fish for oil," said Dr Scott Doughman, the formulating scientist and President of Source-Omega, the maker of Pure One™.

"Most vegetarian algae oil products on the market are still placed in animal capsules. The animal capsules have peroxides which shortens omega-3 shelf life. Unlike others, Pure One™ uses only high grade algae oil and capsules. You get what you pay for with omega-3s. I think we have the top product on the market right now, at one of the most affordable prices," said Doughman.

The 100% plant based ingredients registered with the Vegan Society designates quality standards held by only few select DHA products worldwide. Pure One™ oil is unblemished by the current fish industry problems such as menhaden overfishing and toxic oil spills.

Pure One™ is one product, not a fish oil blend. It starts pure and ends pure. Fish oil cannot claim that and must be decontaminated for human consumption. The source where fish oil omega-3s come from in the food chain is now grown sustainable and scalable away from the sea free of pollution and free of harm to fish, krill, seals and penguins.

Microalgae oil (algae oil) is among the richest marine omega-3 sources. With 3-times the DHA concentration versus fish oil, Pure One's website suggests this means half the numbers of capsules are required per day. Also, flax oil does not provide the marine omega-3s needed by the body for healthy cardiovascular and cognitive function. Most omega-3 benefits are associated with fish and fish oil, but fish are not the only food sources rich in marine fatty acids. Some also fear fish oil is not the safest solution.

"Since 1997, FDA experts have granted our omega-3 oil ( http://www.source-omega.com ) and our grower with a Generally Regarded As Safe designation for algae oil food supplements. We use only conventional enclosed growing techniques without any genetic modification," said Dr Pernilla Karlsson, PhD, a Pure One™ Spokesperson, Author, Toxicologist, Nutritionist, and President of Veganlife in Europe.

Due to the metabolic disadvantages of ALA, alpha-linolenic acid (ALA) rich plant sources, vegetarian flax oil is not as effective as algal omega-3 supplements, studies show. While foods and oils like flax oil, walnuts and mustard seeds are good sources of vegetarian omega 3s, algae oil supplements offer a higher standard of benefits, allowing everyone access to full omega 3 benefits for healthier lifestyles, regardless of culinary affiliations.

"Even if one is not a vegetarian or vegan, Pure One™ gives the maximum benefit of omega 3s because the proper balance of DHA and EPA make it a superior source," said Dr Alex McDonald, M.D., a Pro-athlete and Doctor taking Pure One™ while training for the Iron-Man™ to achieve a peak omega-3 index. Pure One™ sponsors McDonald.

About Source-Omega, LLC
Chapel Hill North Carolina, USA: Source-Omega is located near the Research Triangle Park and was founded in 2007 for specializing in the manufacturing, branding, and globalization of algae oil nutritional products as an exclusive distributor of the brand name Pure One™, Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care. Dr. Scott Doughman, Ph.D. Phone: +19193605275, Web: http://www.PureOne-DHA.com

Press Contact:
Joe Major
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Pure One™ DHA supplement manufacturer today announced a license from the Vegan Society for trademark use in the United States, Canada, the European Union, and Australia. The Vegan logo adds to Pure One’s quality offering for vegetarian consumers and vegan retailers, in addition to the benefits of being sourced and Made in the USA and recognized good for pregnant-nursing mothers and infants.

Chapel Hill, NC -- (SBWIRE) -- 05/23/2010 -- Could Pure One™ be the "4G" of omega-3s? Pure One™ Next Generation Plant Based Omega-3™ may qualify as a brilliant leap forward in omega-3s. Pure One™ is DHA-rich oil from a pure cultured algal source. The oil has significant scientific research backing, a patent pending metabolic ratio of DHA and EPA for the same omega-3s that are found in fish oils, but without the fish. Pure One™ is from one source, not a mixture, and is a pure sustainable product made in a breakthrough vegan softgel, also from natural algae sources. The product is free of animal products, GMO's, wheat & gluten, soy, hexane, fragrance, flavorings, dyes, toxins, allergens, pollutants and heavy metals. See www.PureOne-DHA.com for product information.

"Our research and development brought to market the first and only metabolic ratio of DHA and EPA omega-3s. We are educating consumers that Pure One™ is proven to replace fish oil, dose for dose, for the heart and brain, eliminating the need for the world to harvest fish for oil," said Dr Scott Doughman, the formulating scientist and President of Source-Omega, the maker of Pure One™.

"Most vegetarian algae oil products on the market are still placed in animal capsules. The animal capsules have peroxides which shortens omega-3 shelf life. Unlike others, Pure One™ uses only high grade algae oil and capsules. You get what you pay for with omega-3s. I think we have the top product on the market right now, at one of the most affordable prices," said Doughman.

The 100% plant based ingredients registered with the Vegan Society designates quality standards held by only few select DHA products worldwide. Pure One™ oil is unblemished by the current fish industry problems such as menhaden overfishing and toxic oil spills.

Pure One™ is one product, not a fish oil blend. It starts pure and ends pure. Fish oil cannot claim that and must be decontaminated for human consumption. The source where fish oil omega-3s come from in the food chain is now grown sustainable and scalable away from the sea free of pollution and free of harm to fish, krill, seals and penguins.

Microalgae oil (algae oil) is among the richest marine omega-3 sources. With 3-times the DHA concentration versus fish oil, Pure One's website suggests this means half the numbers of capsules are required per day. Also, flax oil does not provide the marine omega-3s needed by the body for healthy cardiovascular and cognitive function. Most omega-3 benefits are associated with fish and fish oil, but fish are not the only food sources rich in marine fatty acids. Some also fear fish oil is not the safest solution.

"Since 1997, FDA experts have granted our omega-3 oil ( http://www.source-omega.com ) and our grower with a Generally Regarded As Safe designation for algae oil food supplements. We use only conventional enclosed growing techniques without any genetic modification," said Dr Pernilla Karlsson, PhD, a Pure One™ Spokesperson, Author, Toxicologist, Nutritionist, and President of Veganlife in Europe.

Due to the metabolic disadvantages of ALA, alpha-linolenic acid (ALA) rich plant sources, vegetarian flax oil is not as effective as algal omega-3 supplements, studies show. While foods and oils like flax oil, walnuts and mustard seeds are good sources of vegetarian omega 3s, algae oil supplements offer a higher standard of benefits, allowing everyone access to full omega 3 benefits for healthier lifestyles, regardless of culinary affiliations.

"Even if one is not a vegetarian or vegan, Pure One™ gives the maximum benefit of omega 3s because the proper balance of DHA and EPA make it a superior source," said Dr Alex McDonald, M.D., a Pro-athlete and Doctor taking Pure One™ while training for the Iron-Man™ to achieve a peak omega-3 index. Pure One™ sponsors McDonald.

About Source-Omega, LLC
Chapel Hill North Carolina, USA: Source-Omega is located near the Research Triangle Park and was founded in 2007 for specializing in the manufacturing, branding, and globalization of algae oil nutritional products as an exclusive distributor of the brand name Pure One™, Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care. Dr. Scott Doughman, Ph.D. Phone: +19193605275, Web: http://www.PureOne-DHA.com

Press Contact:
Joe Major
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm